Top Markets
#1 MowCat MowCat +48.94%
#2 Velvet Velvet +24.42%
#3 Bermuda Shorts Bermuda Shorts +24.20%
#4 Quack AI Quack AI +22.94%
#5 Derive Derive +20.22%
#6 Audiera Audiera +19.04%
#7 Biconomy Biconomy +18.54%
#8 Geodnet Geodnet +14.53%
#9 aPriori aPriori +14.25%
#10 SkyAI SkyAI +13.63%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Roopa Industries Limited Roopa Industries Limited

Roopa Industries Limited

ROOPAIND
Rank in Stocks #35239
Established on June 17, 1985, Roopa Industries Ltd. is a pharmaceutical... Established on June 17, 1985, Roopa Industries Ltd. is a pharmaceutical manufacturing company based in Hyderabad, India. Its product offerings include triphenyl phosphine, glucosamine, and various bromine compounds.
Share Price
$0.53711615
Last synced: 2026-08-14
Market Cap
$4.22M
Change (1 day)
-0.63%
Change (1 year)
-12.78%
Country
IN
Trade Roopa Industries Limited (ROOPAIND)

Category

Healthcare
Earnings for Roopa Industries Limited (ROOPAIND)
Earnings in 2026 TTM: 0
According to Roopa Industries Limited latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Roopa Industries Limited from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US